Job Description
- Date: 1/10/2024 - 30/9/2025
- Send a curriculum vitae and a motivation letter to Prof Jean-Pascal Machiels: jean-pascal.machiels@saintluc.uclouvain.be before January 31st 2024.
- The candidates will be personally contacted soon after their application.
The fellow will be integrated in the activity of the medical oncology department, with a particular focus on phase 1 trials. He will also be involved in the weekly molecular tumor board.
Through this fellowship, the clinician will have the opportunity:
- To have a one-year diving experience in daily management of phase 1 trials.
- To participate to the daily treatment unit and consultation activities of the cancer centre.
- To gain in depth knowledge in precision oncology, by preparing and discussing the clinical and molecular data of patients for the weekly loco-regional molecular tumor board.
- To participate to the national molecular tumor board.
- To develop a clinical research project that could be conducted jointly in his and our hospital/university.
- To attend high-level scientific seminars in the field of clinical oncology and translational research.
This will provide the fellow a true opportunity to foster a long-term clinical collaboration and enlarge his/her clinical and scientific network.
The salary wil be similar to the ones of the Belgium fellows in training (medical oncology). Fellows with their own salary funded via their university or external funding scheme may also apply.
Training Experience Required
- Fellow in training in medical oncology with already some significant clinical experience in oncology
- Speak French fluently
- Hold a MD diploma that will be recognized by the Belgium authorities
General Description
Cliniques Universitaires Saint-Luc is a general academic hospital located in Brussels, and the partner university hospital of UCLouvain (French-speaking university).
Expertise
- Our clinicians are internationally recognized experts in head and neck cancer, uveal melanoma, breast cancer, digestive cancers, …
- The medical oncology department has its own translational research laboratory, focusing on head and neck, colorectal, breast and skin cancers. We are physically located on the same site as many cancer research laboratories of UCLouvain (de Duve Institute, Ludwig Institute for Cancer Research and others). This provides a true opportunity to attend high-level scientific seminars and foster a network with translational research specialists (ie in the field of immunology, microbiome, tumor metabolics, tumor imaging, …).
- Our phase I unit has expertise in first-in-man and dose-escalation with more than 25 trials open for inclusion.
- We host a weekly molecular tumor board (> 800 cases discussed in 3 years) attented by medical oncologists and cancer organ specialists of 6 other partner hospitals. Our team also contributes to the weekly national molecular tumor board, discussing patients included in national driven precision oncology trials.
- We have a fully integrated EMR (Epic) with highly structured data level. We are main actors of a large research consortia dedicated to real-world data research (Digicore Cancer), providing the opportunity to develop a collaborative real-world data driven study protocol.
Facilities
Institut Roi Albert II is the comprehensive cancer centre of the hospital. It is the largest oncology centre for adult and pediatric cancers in Brussels and the French-speaking part of Belgium.
Last update: August 2023
